Routine RTA certificate on demat/remat requests for Q2 FY26

Compliance View source PDF Explain this filing

NEPHROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹86.15

prior close

₹87.40

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+1.5% vs market

On the reaction day the stock moved 1.5 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-0.2-1.6+1.5

Next day

-0.2-1.0+0.8

-1.3-2.6+1.3

-0.8-5.1+4.4

-0.2-6.1+5.9

-3.7-8.3+4.6

-8.3pendingpending

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nephro Care India has submitted a certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2026, issued by its Registrar and Transfer Agent, Bigshare Services. The RTA confirms that no shareholder made any request for dematerialisation or rematerialisation of shares during the quarter. This is a standard quarterly compliance submission required of listed companies.

Likely market impact

Routine compliance filing with no material impact on business, financials, or share price for retail investors.